Ayaaz Hussain Khan, PhD


Navigating Data Integrity for Generic Drug Approvals

Continuous innovation is required in various technological aspects to effectively manage the challenges of vast clinical data.

Keith Wellman, PharmD, BCPS, MBA


Multiple Myeloma Pipeline Offers Promising New Options for Treatment

Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.

Amber Suthers, CPhT, MSAH, and Beth Bryan, PharmD


Pharmacy Is Ready to Embrace Expanded Roles

Pandemic allows technicians to shine and be increasingly viewed as key to streamlining workflow.

Gauri Sabnis, PhD


Case Study: Insulin Sensitizers as Enhancers in Diabetes Management

The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.

Gabrielle Ruggiero, PharmD, BCPS


Oncology Overview: Tucatinib for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer

Tucatinib is indicated to treat adults with advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have already received at least 1 anti-HER2-based regimen in the metastatic setting.

Allison T. Rhoads, PharmD


Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical Cancer

Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

Krishna Kurapati


Accelerate Time to Specialty Pharmacy Therapy with Digital Options

Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.

Eric Berberian, PharmD candidate


Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.

Amer El-Ghali, PharmD


2022-2023 Influenza Season Looks to Be Severe

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.

Todd Watkins


Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.

Mickenzie Meyers, PharmD Candidate


2022 ACC Consensus on Role of Nonstatin Therapies for LDL-Cholesterol Lowering

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

Javier Munoz, MD, MBA


Future Treatment Landscape of MZL

Closing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.

Ken Perez


The Societal Case for Pharmacist Provider Status

Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.

Liz Hess, PharmD, MS, FISMP, CPPS


Wellness Support Group Shows Promise in Reducing Burnout

Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.

Bradley J. Monk, MD, FACS, FACOG


Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer Treatment

Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.

Libby Baney, JD


Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug Sellers

Although approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.

Katelyn Galli, PharmD, BCCP


Increased Development of RSV Immunoprophylaxis Inhibited by Cost and Acquisition Barriers

Despite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.

Jenna Januszka, PharmD


Monkeypox Treatment and Prevention: Stopping the Latest Outbreak

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.

Anu Tirupasur


Learn to Mitigate Feelings of Burnout and Stress

Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.

Luis A. Valcarcel, PharmD Candidate


Changing the Game: Pharmacy Students' Perspective on Naloxone OTC Approval

To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.

Stephanie Ostling Mason, PharmD, CDCES


New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic Management

The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.

Aric Logsdon, PhD


Topical Ketamine: A Promising New Avenue for PTSD Treatment

Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.

Diana Roskova


Pain Management in the ICU Is Complex

Finding the right medication or drug combination for individual patients is critical.

Michael Leighton, PharmD, MBA


Proposed FDA Rule on Patient Medication Information Seeks to Address Prescription Misuse, Nonadherence

Improved prescription information could help consumers make better health care decisions and result in cost savings.

Susan W. Lanham, PhD, MAFF, CDFA


Gabapentin Presents High Potential for Misuse

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.

Ashley Sauro, PharmD, BCPS


Implementing USP <800> Guidelines in Pediatric Hospitals

Protecting this vulnerable patient population requires specially designed strategies.

Abbey M. Natour


Respect State Marijuana Laws Act of 2017 Amends Previous Legislation

Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.

© 2024 MJH Life Sciences

All rights reserved.